PHARMACEUTICAL COMPOSITION AND USE FOR THE THERAPEUTIC MANAGEMENT OF EXTRAUTERINE PROLIFERATION OF ENDOMETRIAL TISSUE

摘要

The invention relates to a pharmaceutical composition for the therapeutic control of ectopic endometrial tissue proliferation comprising an LHRH antagonist selected from the group consisting of centrorelix, teverelix, ganyrelix, andit, abarelix and osarelix and optionally one or more active substances selected from a contraceptive , non-steroidal anti-rheumatic agent, analgesic, androgen other than 17-alpha-alkyl substituted testosterone or combinations.